Page 20 - Segments Profiled News Today

During the forecast period 2023 to 2033, the IgA nephropathy market is expected to grow at a value of 7.5% CAGR, according to Future Market Insights. By the year 2033, the global market for IgA nephropathy is expected to rise up to a market valuation of US$ 85 Billion. Key factors such as high prevalence of kidney d...

In 2023, the global respiratory distress syndrome management market is expected to be worth US$ 115.4 billion. According to Future Market Insights, the market is expected to grow at a 4.41% CAGR until 2033, valued at US$ 177.7 billion, according to Future Market Insights. Furthermore, according to a recent FMI study...

According to a recent Future Market Insights analysis, the global hyperammonemia treatment market is anticipated to reach a valuation of US$ 1,318.05 Million in 2023 and US$ 2,100 Million by 2033, with a CAGR of 4.77%.The increased frequency of urea cycle diseases, as well as extensive research and development, are...

A recently published study by FMI expects the global alcohol use disorder treatment market demand to augment at a 6.4% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 1300 million is expected for the market. The growing number of drug awareness campaigns, preventative programs, a...

Some of the key players in the Vascular Dementia Treatment Market are- Charsire Biotechnology Corp, ProNeurogen Therapeutics, Resverlogix Corp., Eisai Co.,...

During the forecast period 2023 to 2033, the Secondary Myelofibrosis Therapeutics Market is expected to grow at a value of 6.3% CAGR, according to Future Market Insights. By the year 2033, the global market for Secondary myelofibrosis therapeutics is expected to rise up to a market valuation of US$ 2.74 Billion. Gro...

The global paediatric obesity management market is anticipated to reach a market value of US$ 3.2 billion in 2023 and to reach US$ 4.74 billion by registering a CAGR of 4% from 2023 to 2033. From 2018 to 2022, the market for paediatric obesity management experienced a 3% CAGR.The global prevalence of pediatric obesi...

During the forecast period 2023 to 2033, the Salivary Gland Infection Treatment Market is expected to grow at a value of 9.3% CAGR, according to Future Market Insights. By the year 2033, the global market for Salivary gland infection treatment is expected to rise up to a market valuation of US$ 12,300 Million. Growt...

Between 2022 and 2032, the global multiple endocrine neoplasia market is expected to develop at a high CAGR of over 6.0%. The key force driving the worldwide multiple endocrine neoplasia market is rising consumption of multiple endocrine neoplasia drugs to alleviate symptoms and improve quality of life.Multiple endo...

According to a recent study published by Future Market Insights, the market for Oncolytic Virus Cancer Therapy is forecast to reach a valuation of US$ 22.86 Million by 2023-end, and will eventually reach US$ 250 Million by 2033, growing at an astronomical CAGR of 27%. Governments in various emerging economies have c...